tadalafil biomo 5mg film-coated tablets
biomo pharma gmbh josef-dietzgen-straße 3, d-53773, hennef,, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals
tadalafil welding 5mg film-coated tablets
welding gmbh & co. kg esplanade 39, 20354, hamburg, germany - tadalafil - film-coated tablet - tadalafil 5 milligram(s) - urologicals
tadalafil welding 10mg film-coated tablets
welding gmbh & co. kg esplanade 39, 20354, hamburg, germany - tadalafil - film-coated tablet - tadalafil 10 milligram(s) - urologicals
tadalafil welding 20mg film-coated tablets
welding gmbh & co. kg esplanade 39, 20354, hamburg, germany - tadalafil - film-coated tablet - tadalafil 20 milligram(s) - urologicals
tadalafil aristo pah 20mg film-coated tablets
aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals
filgrastim ratiopharm
ratiopharm gmbh - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - immunostimulants, - filgrastim ratiopharm is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.filgrastim ratiopharm is indicated for the mobilisation of peripheral blood progenitor cells (pbpc).in patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of 0.5 x 109/l, and a history of severe or recurrent infections, long term administration of filgrastim ratiopharm is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.filgrastim ratiopharm is indicated for the treatment of persistent neutropenia (anc less than or equal to 1.0 x 109/l) in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.
removab
neovii biotech gmbh - catumaxomab - ascites; cancer - other antineoplastic agents - removab is indicated for the intraperitoneal treatment of malignant ascites in patients with epcam-positive carcinomas where standard therapy is not available or no longer feasible.,
ramipril tad 1.25 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 1.25 mg - agents acting on the renin-angiotensin system
ramipril tad 2.5 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 2.5 mg - agents acting on the renin-angiotensin system
ramipril tad 5 mg tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 5 mg - agents acting on the renin-angiotensin system